These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 12496409)

  • 1. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice.
    Bronte V; Serafini P; De Santo C; Marigo I; Tosello V; Mazzoni A; Segal DM; Staib C; Lowel M; Sutter G; Colombo MP; Zanovello P
    J Immunol; 2003 Jan; 170(1):270-8. PubMed ID: 12496409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype.
    Munder M; Eichmann K; Modolell M
    J Immunol; 1998 Jun; 160(11):5347-54. PubMed ID: 9605134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection.
    Brys L; Beschin A; Raes G; Ghassabeh GH; Noël W; Brandt J; Brombacher F; De Baetselier P
    J Immunol; 2005 May; 174(10):6095-104. PubMed ID: 15879104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide-independent CTL suppression during tumor progression: association with arginase-producing (M2) myeloid cells.
    Liu Y; Van Ginderachter JA; Brys L; De Baetselier P; Raes G; Geldhof AB
    J Immunol; 2003 May; 170(10):5064-74. PubMed ID: 12734351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gr-1+ myeloid cells lacking T cell protein tyrosine phosphatase inhibit lymphocyte proliferation by an IFN-gamma- and nitric oxide-dependent mechanism.
    Dupuis M; De Jesús Ibarra-Sánchez M; Tremblay ML; Duplay P
    J Immunol; 2003 Jul; 171(2):726-32. PubMed ID: 12847239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.
    Mazzoni A; Bronte V; Visintin A; Spitzer JH; Apolloni E; Serafini P; Zanovello P; Segal DM
    J Immunol; 2002 Jan; 168(2):689-95. PubMed ID: 11777962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism.
    Hesse M; Modolell M; La Flamme AC; Schito M; Fuentes JM; Cheever AW; Pearce EJ; Wynn TA
    J Immunol; 2001 Dec; 167(11):6533-44. PubMed ID: 11714822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells.
    Munder M; Eichmann K; Morán JM; Centeno F; Soler G; Modolell M
    J Immunol; 1999 Oct; 163(7):3771-7. PubMed ID: 10490974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
    Sinha P; Clements VK; Ostrand-Rosenberg S
    Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.
    Apolloni E; Bronte V; Mazzoni A; Serafini P; Cabrelle A; Segal DM; Young HA; Zanovello P
    J Immunol; 2000 Dec; 165(12):6723-30. PubMed ID: 11120790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
    Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
    J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid suppressor cell-associated immune dysfunction in CSA1M fibrosarcoma tumor-bearing mice.
    Zhou R; He PL; Ren YX; Wang WH; Zhou RY; Wan H; Ono S; Fujiwara H; Zuo JP
    Cancer Sci; 2007 Jun; 98(6):882-9. PubMed ID: 17433038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation.
    Kusmartsev SA; Li Y; Chen SH
    J Immunol; 2000 Jul; 165(2):779-85. PubMed ID: 10878351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid arginase-1 controls excessive inflammation and modulates T cell responses in Pseudomonas aeruginosa pneumonia.
    Haydar D; Gonzalez R; Garvy BA; Garneau-Tsodikova S; Thamban Chandrika N; Bocklage TJ; Feola DJ
    Immunobiology; 2021 Jan; 226(1):152034. PubMed ID: 33278710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-arginine metabolism in myeloid cells controls T-lymphocyte functions.
    Bronte V; Serafini P; Mazzoni A; Segal DM; Zanovello P
    Trends Immunol; 2003 Jun; 24(6):302-6. PubMed ID: 12810105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.
    Sinha P; Clements VK; Ostrand-Rosenberg S
    J Immunol; 2005 Jan; 174(2):636-45. PubMed ID: 15634881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
    Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
    J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.
    Gallina G; Dolcetti L; Serafini P; De Santo C; Marigo I; Colombo MP; Basso G; Brombacher F; Borrello I; Zanovello P; Bicciato S; Bronte V
    J Clin Invest; 2006 Oct; 116(10):2777-90. PubMed ID: 17016559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T cell proliferation: interferon-gamma is essential but insufficient.
    van der Veen RC; Dietlin TA; Pen L; Gray JD; Hofman FM
    Cell Immunol; 2000 Dec; 206(2):125-35. PubMed ID: 11161444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production.
    Rutschman R; Lang R; Hesse M; Ihle JN; Wynn TA; Murray PJ
    J Immunol; 2001 Feb; 166(4):2173-7. PubMed ID: 11160269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.